School of Medicine
Showing 1-10 of 38 Results
Russell K Pachynski, MD
Instructor, Medicine - Oncology
Current Research and Scholarly Interests The recruitment of key effector immune cells to the tumor microenvironment is critical for improving outcomes in cancer treatment. Our research has focused on evaluation of a novel leukocyte chemoattractant, chemerin. We have shown it can act as a tumor suppressive cytokine by marshaling the host immune system and skewing the number and ratio of key anti-tumor effector cells at the site of tumor. We are continuing our preclinical studies of chemerin, and plan to expand the general approach.
Clinical Assistant Professor, Medicine - General Medical Disciplines
Bio Medical Director, Stanford Concierge Medicine and Stanford Executive Health
Board Certified Internal Medicine
Board Certified Hospice and Palliative Medicine
Alan C. Pao
Assistant Professor of Medicine (Nephrology) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests We are interested in the hormonal and signal transduction pathways that control epithelial ion transport. Our model system involves tight epithelia, typically found in the distal nephron of the kidney. Clinical implications of our work include a better understanding of the pathogenesis of salt-sensitive hypertension and hypertension associated with the insulin resistance syndrome.
Postdoctoral Research fellow, Cardiovascular Medicine
Current Research and Scholarly Interests Describe your current research interest and activities
Assistant Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
Professor of Medicine, Emerita
Current Research and Scholarly Interests The lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.